Page 156 - SAMRC Annual Report 2024-2025
P. 156

Precision and Genomic
                                                               Medicine Research Unit





                                                               Unit director:
                                                               Prof. Raj Ramesar
                                                               Raj.Ramesar@uct.ac.za






            Advancing Research Priorities:                     and managing CRCs to improve the ascertainment

            Strategic Objectives and Impact                    of all familial CRCs, since they can be managed
                                                               successfully in families, to reduce morbidity and
            The  Precision  and  Genomic Medicine Research     mortality.
            Unit’s  emphasis  has  primarily  focused  on  creating
            evidence that identify hereditary forms of disease,   Additionally, the identification of genetic signatures
            and their pre-symptomatic management, improves     in circulating blood (liquid biopsy) of presymptomatic
            the lives of those at highest risk.                disease-causing mutation carriers, promises to
                                                               replace  highly invasive  and  expensive  endoscopic
            In this regard, the project that leads are the 'genomics
            of familial colorectal cancers' project, which aims   surveillance modalities.
            to improve the ascertainment of patients with a    The establishment of a national South African National
            familial form of the colorectal cancer (as common   Cancer Prevention Services (SANCAPS) collaborative
            as 1/300 individuals), from a background of sporadic   that involves a wide range of specialists who are
            colorectal cancers. The use of predictive genetic   involved in the diagnosis and management of familial
            testing  and clinical surveillance  has proven  to be   colorectal cancers (including The National Cancer
            highly  effective  in the reduction  of  morbidity  and   Registry within the NHLS, Oncologists, Anatomical
            mortality, with associated socio-economic benefits.
                                                               Pathologists,  Surgeons,    Gastroenterologists,
            Of  particular  significance,  in  maintaining  a  strong   Family Physicians and Geneticists) with a vision of
            research programme attached to our community work   ascertaining all likely familial CRCs and managing
            amongst rural populations, is the recognition that   at-risk  families  preventatively. Importantly, this is
            adherence to invasive endoscopic (i.e. colonoscopic   a forerunner or will serve to set a template for a
            and gynae) screening is counterproductive. Current   Register and management protocols for all familial
            research has been based on improving this screening   cancers (including breast/ovarian, amongst others)
            by investigating liquid biopsy (i.e. circulating blood)   attached to the National Cancer Register, but with
            for genetic signatures as markers of neoplasia in   active engagement with the Provincial Departments
            those at highest risk. Current indicators are very   of Health to ensure sustainability. Of particular
            promising and have the potential of non-invasive   importance, this is leading to bright young clinicians
            surveillance, as well as remarkably reduced cost of   (a Surgeon and an Anatomical Pathologist) at e.g.
            such surveillance.                                 Inkosi Chief Albert Luthuli Hospital/UKZN to register
                                                               for PhDs on the genomics of colorectal cancers
            Key Milestones and Achievements                    since they have seen the translatability of this work
            Development of  an AI-based app that is used by    towards reducing morbidity and mortality amongst
            all in the team who are involved  with diagnosing   their patients.







            154         SAMRC  ANNUAL REPOR T 2024-25
   151   152   153   154   155   156   157   158   159   160   161